Bolt Biotherapeutics, Inc. - Common Stock - relatórios financeiros (NASDAQ:BOLT) | MetaTrader

Abrir gráfico completo Full chart

Notícias

Rodman & Renshaw inicia cobertura da Bolt Biotherapeutics com recomendação de compra

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

CEO da Bolt Biotherapeutics, Quinn, compra ações no valor de US$ 686

Sarah Nemec, VP da Bolt Biotherapeutics, adquire ações no valor de US$ 686

Bolt Biotherapeutics CEO Quinn buys shares worth $686

Nemec, Bolt Biotherapeutics SVP, acquired shares worth $686

Bolt Biotherapeutics inicia cobertura com recomendação de Compra pela H.C. Wainwright

Bolt Biotherapeutics stock initiated with Buy rating at H.C. Wainwright

Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Mr. Cooper Gr (NASDAQ:COOP), Bolt Biotherapeutics (NASDAQ:BOLT)